Clinical Research Center Prof. Fulvio Pileggi

Instituto do Coracao

Vascular Diseases

Lung Diseases

Hypertension

Respiratory Tract Diseases

Pulmonary Hypertension

Pulmonary Arterial Hypertension

Connective Tissue Diseases

Cardiovascular Diseases

Familial Primary Pulmonary Hypertension

Bacteremia

Ralinepag

N-acetylcysteine

United Therapeutics

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Instituto do Coracao | Clinical Research Center Prof. Fulvio Pileggi

Site insights

Work at this site?

Active trials

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Trial sponsors